ut-logo website  
 
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

You are here:
Home

zoledronic acid:

1. Treatment of Castration Resistant Prostate Cancer
... prostate cancer. Nat Rev Cancer  2001; 1:34-45. Fizazi K, Carducci M, Smith M, et al: Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate ...
2. Beyond the Abstract - A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy, by Atsushi Mizokami, MD, et al.
BERKELEY, CA (UroToday.com) - Bone, lung, pleural and liver metastases from renal cell carcinoma (RCC) are common sites.
3. Beyond the Abstract - Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: A safe and additively effective practice, by Athanasios Zafeirakis, MD, PhD
BERKELEY, CA (UroToday.com) - Treatment with 186 Rhenium-l,l-hydroxyethylidene diphosphonate (186Re-HEDP) has long been proven safe for palliation of bone pain in patients with widespread osseous metastases. ...
4. Beyond the Abstract - Metronomic administration of zoledronic acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial, by Michele Caraglia, MD, PhD
BERKELEY, CA (UroToday.com) - Recently it was demonstrated that a 3-weekly schedule of docetaxel (DTX) and prednisone is the standard first-line chemotherapy for patients with hormone-refractory prostate ...
5. Beyond the Abstract - Does valproic acid induce neuroendocrine differentiation in prostate cancer? by Abhinav Sidana, MD
BERKELEY, CA (UroToday.com) - Histone acetylation and deacetylation by histone acetyl transferases and histone deacetylases (HDACs) is involved in the epigenetic regulation in human cells.1, 2
6. Beyond the Abstract - Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases, by Jipan Xie, MD, PhD
BERKELEY, CA (UroToday.com) - Commentary on the Cost-Effectiveness of Denosumab vs. Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases ...
7. Beyond the Abstract - Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis, by Robert E. Hurst, PhD
BERKELEY, CA (UroToday.com) - Interstitial cystitis (IC) represents a real conundrum for the urologist.
8. Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells, "Beyond the Abstract," by Kathryn E. Meier, PhD
BERKELEY, CA (UroToday.com) - Calpains (calcium-activated proteases) were initially thought to participate primarily in cellular events in which intracellular calcium levels rise to catastrophically high ...
9. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through up-regulation of cathepsin B, "Beyond the Abstract," by Thomas Beckham and Xiang Liu
BERKELEY, CA (UroToday.com) - Tumor-shed vesicles mediate tumor–stroma interactions in acid ceramidase over expression cells
10. AUA 2013 - Session Highlights: Determination of tissue injury threshold from focused therapeutic ultrasound
SAN DIEGO, CA USA (UroToday.com) - Therapeutic ultrasound has an increasing number of applications in urology, including shockwave lithotripsy, stone propulsion, tissue ablation, and hemostasis.